Skip to content
10-K

Annual Report

Summit Therapeutics Inc. SMMT

0001599298-26-000015

← back to feed
Filed
Feb 23, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 17, 2026 775.37M sh
Shares Diluted FY 2025 · Dec 31, 2025 747.7M sh
Shares Diluted FY 2025 · Dec 31, 2024 718.54M sh
Shares Diluted FY 2025 · Dec 31, 2023 619.65M sh
Capex FY 2025 · Dec 31, 2025 $657K
Capex FY 2025 · Dec 31, 2024 $139K
Capex FY 2025 · Dec 31, 2023 $128K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$322.93M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$142.11M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$76.76M
Short Term Investments FY 2025 · Dec 31, 2025 $488.18M
Short Term Investments FY 2025 · Dec 31, 2024 $307.49M
Cash And Equivalents FY 2025 · Dec 31, 2025 $225.27M
Cash And Equivalents FY 2025 · Dec 31, 2024 $104.86M
Cash And Equivalents FY 2025 · Dec 31, 2023 $71.43M
Stockholders Equity FY 2025 · Dec 31, 2025 $658.86M
Stockholders Equity FY 2025 · Dec 31, 2024 $388.75M
Stockholders Equity FY 2025 · Dec 31, 2023 $77.69M
Stockholders Equity FY 2025 · Dec 31, 2022 $126.65M
Current Liabilities FY 2025 · Dec 31, 2025 $72.99M
Current Liabilities FY 2025 · Dec 31, 2024 $41.73M
Total Liabilities FY 2025 · Dec 31, 2025 $92.32M
Total Liabilities FY 2025 · Dec 31, 2024 $46.81M
Current Assets FY 2025 · Dec 31, 2025 $720.3M
Current Assets FY 2025 · Dec 31, 2024 $423.75M
Total Assets FY 2025 · Dec 31, 2025 $751.18M
Total Assets FY 2025 · Dec 31, 2024 $435.56M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.44
Eps Diluted FY 2025 · Dec 31, 2024 −$0.31
Eps Diluted FY 2025 · Dec 31, 2023 −$0.99
Eps Basic FY 2025 · Dec 31, 2025 −$1.44
Eps Basic FY 2025 · Dec 31, 2024 −$0.31
Eps Basic FY 2025 · Dec 31, 2023 −$0.99
Sga Expense FY 2025 · Dec 31, 2025 $556.75M
Sga Expense restated FY 2025 · Dec 31, 2024 $60.21M
Sga Expense restated FY 2025 · Dec 31, 2023 $29.26M
Net Income FY 2025 · Dec 31, 2025 −$1.08B
Net Income FY 2025 · Dec 31, 2024 −$221.32M
Net Income FY 2025 · Dec 31, 2023 −$614.93M